Remote ischemic preconditioning in patients with aneurysmal subarachnoid hemorrhage

Not Applicable

Recruiting

• Conditions: I60.7; I63.9; Subarachnoid haemorrhage from intracranial artery, unspecified; Cerebral infarction, unspecified

• Registration Number: DRKS00011177
• Lead Sponsor: eurochirurgische Klinik und Poliklinik, Klinikum rechts der Isar

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-09-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients suffering from aneurysmal subarachnoidal bleeding
- written consent for study participation by patient, family member or by an independent physician in case of inability to consent
- age > 18 years

Exclusion Criteria

- peripheral arterial disease
- time after hemorrhage >48 hours
- diabetes mellitus and intake of oral antidiabetic medication
- inability to consent
- pregnancy
- age< 18 years

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Volumetry of ischemic area con cranial CT scan 2 to 3 weeks post subarachnoid hemorrhage

Secondary Outcome Measures

Name	Time	Method
Secondary outcome is the severity of neurological impairment, which will be scored by the National Institutes of Health Stroke Scale (NIHSS) at time at admission to the hospital, 1 and 2 weeks, 3 months and 1 year after bleeding and by the Modified Rankin Scale (mRS) at discharge, 3 months and 1 year after bleeding. Furthermore, doppler studies will be conducted daily for the detection of vasospasm.